International Team

Our Team

Our success is driven by a world-class team of professionals. With seasoned management and a board with extensive experience in both Big Pharma and early-stage biotech, we are well-equipped to navigate the complexities of drug development and generate substantial value for all stakeholders.

The scientific advisory board for our first indication is made up of renowned scientists and clinicians, namely Prof. Roger Stupp (Northwestern), Prof. Mitch Berger (UCSF), Prof. Nicolas de Tribolet (UNIGE), Prof. Ariel Ruiz i Altaba (UNIGE) and Prof. Pierre Magistretti (EPFL).

Management team

BOARD OF DIRECTORS

WORLD CLASS GBM CLINICAL & SCIENTIFIC ADVISORY BOARD

PLATFORM SCIENTIFIC FOUNDERS​

Cytea bio - a pipeline company of Medxcell 

CYTEA BIO is a pipeline company of MedXCell, a Swiss venture builder. CYTEA BIO has been founded and financed by MedXCell, gaining access to crucial skills to advance its programs. CYTEA BIO  is now in the process of raising its first external funding.